All assets associated with the tag: cancer research
Durham-based biotechnology startup Tavros Therapeutics has announced its second collaboration in six months to find new targets and therapies for cancer. Here's the latest in our Startup Spotlight.
Researchers have identified new genetic mutations linked to a subset of canine bladder cancers. Their findings have implications both for early cancer detection and for targeted treatments in dogs and humans.
Clinical trials are showing an immune response that indicates it might prevent a certain kind of breast cancer.
Labcorp is partnering with the Conference of National Black Churches to address health equity gaps in colorectal cancer screening. Here are the details.
The V Foundation for Cancer Research recently announced a new multi-million dollar grant research program focused on improving female representation and increasing female-led innovations in cancer research.
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
KECSKEMÉT, Hungary -- Inside a dark room at Bács-Kiskun County Hospital outside Budapest, Dr. Éva Ambrózay, a radiologist with more than two decades of experience, peered at a computer monitor showing a patient's mammogram.
Adam Satariano and Cade Metz, New York Times
G1 Therapeutics,which is focused on oncology research, will no longer seek to explore one of its drug candidates as a treatment for colorectal cancer, the company announced Monday.
Researchers are developing a new method to treat this lethal disease. Their study, recently published in Nature Biomedical Engineering, combined an injectable radioactive gel with systemic chemotherapy in multiple mouse models of pancreatic cancer. The treatment resulted in tumor regression in all their evaluated models, an unprecedented result for this genetically diverse and aggressive type of cancer.
Genetic studies usually recruit non-Hispanic white men, despite data showing that Black men are disproportionately affected by prostate cancer and more than twice as likely to die from the disease compared to their white counterparts. A new Duke study may help address that problem.
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.
A new predictive model could reduce overtreatment of women with breast pre-cancers called ductal carcinoma in situ, researchers including one from Duke University say.
Marcel Frenkel, co-founder and CEO of Durham-based drug company Ten63 Therapeutics, never thought he’d be focusing the majority of his time and energy on the fight against cancer. Here's how that battle came about and how his mother's fight inspired him. "This idea that there was nothing we could do, I just couldn't accept that," he explains.
Biomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mouse models. What could this mean for the battle against the deadly disease?
PPD, the Wilmington-based clinical research business of Thermo Fisher Scientific, has been awarded a 10-year contract by the National Cancer Institute to support cancer clinical trials.
In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.
A Durham startup focusing on improving outcomes from prostate cancer surgery now has $6.6 million in its tool chest to further advance its research and development.
A young Rhode Island entrepreneur used his love of baking to raise money for cancer research and ended up with iced tea named after him.
Fred Reagan is known as "the candy man." The 77-year-old Massachusetts man is preparing for his 17th Boston marathon jimmy fund walk in October. His goal this year is to raise $20,000 for Dana-Farber cancer institute. Reagan hopes to sell 100,000 candy bars by October.
Morrisville-based Inceptor Bio has a new partner, the University of Minnesota to create a new cell-based tool to fight difficult-to-treat cancers.
A Wake Forest woman who was leading up the fundraising effort for Saturday's gala died in January. Metastatic breast cancer took her life at just 42.
Debra Morgan, WRAL anchor/reporter
Duke University has launched research into what cancer-causing chemicals Durham firefighters are exposed to -- both on and off duty.
Drug giant GlaxoSmithKline is stepping up its efforts to combat cancer, announcing early Wednesday that it is buying California-based Sierra Oncology in a deal valued at $1.9 billion.
A team of North Carolina scientists has developed an implantable scaffold resembling a “mini marshmallow” that produces and releases CAR-T cells for attacking cancerous tumors.
Fourteen years ago, the founders of Incyclix Bio were part of a different team with a shared vision – seven words scrawled on a lab whiteboard at the University of North Carolina at Chapel Hill – “It’s a good day to cure cancer.” Now they have $30 million to keep searching for a cure.